Caricamento...
Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
Mesenchymal epithelial transition factor receptor (Met) is a receptor tyrosine kinase that plays a critical role in promoting cancer cell malignant progression. Met is activated by its ligand hepatocyte growth factor (HGF). HGF-dependent Met activation plays an important role in stimulating epitheli...
Salvato in:
| Pubblicato in: | Clin Transl Med |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883993/ https://ncbi.nlm.nih.gov/pubmed/26932375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-014-0030-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|